Dr Lane considered in 1979 that a redeveloped BPL could be commissioned to increase production capacity to 90 million international units between 1985 and 1990, as an intermediate stage, and then to scale up production to 120 million units for the years that followed.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Self-Sufficiency
Key Person(s)
Dr Richard S Lane